Collision tumor of low-grade B-cell lymphoma and adenocarcinoma with tuberculosis in the colon: a case report and literature review by Hung-Hsin Lin et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Lin et al. World Journal of Surgical Oncology 2014, 12:147
http://www.wjso.com/content/12/1/147CASE REPORT Open AccessCollision tumor of low-grade B-cell lymphoma
and adenocarcinoma with tuberculosis in the
colon: a case report and literature review
Hung-Hsin Lin1,2, Jeng-Kai Jiang1,2 and Jen-Kou Lin1,2*Abstract
This report presents a case of collision tumors of low-grade B-cell lymphoma and adenocarcinoma in the sigmoid
colon of an 81-year-old man. All surgically resected regional mesenteric lymph nodes were found to be occupied
by low-grade B-cell lymphoma, and one lymph node showed the presence of adenocarcinoma. Low-grade B-cell
lymphoma was also observed in the resected spleen. Moreover, concurrent tuberculosis infection in the resected
colon was proven by the presence of positive results obtained with polymerase chain reaction analysis of the
mycobacterial DNA. Systemic chemotherapy was administered for advanced colon cancer with lung metastasis,
and anti-tuberculosis treatment was also prescribed. The occurrence of synchronous lymphoma and adenocarcinoma
of the colorectal region is rare. Furthermore, collisions of these different entities are also extremely unusual.
The accurate clinical determination of the dominant tumor and a timely follow-up are required for the proper
treatment of these cases.
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Only a small number of studies on collision tumors of
lymphoma and colorectal adenocarcinoma exist [1-8]. In
non-Hodgkin’s lymphoma (NHL), the gastrointestinal
tract is the most frequently involved extranodal site, with
the stomach being the most common location (50% to
60%) followed by the small intestine (30%). Primary
lymphoma of the colon is rare, comprising only 0.2% to
1.2% of all colonic malignancies [9]. Additionally, colon
lymphomas represent 5.6% to 20% of all gastrointestinal
lymphomas [10]. Furthermore, lymphoma synchronously
accompanied by adenocarcinoma of the colon is ex-
tremely rare [6].
Case presentation
An 81-year-old man presented to the Department of
Chest Medicine as an outpatient with a chronic dry cough
persisting for 1 month. There were no other systemic* Correspondence: jklin@vghtpe.gov.tw
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unless otherwise stated.symptoms, excluding hypertension and benign prostate
hyperplasia. Chest radiography revealed a 3.2-cm nodule
in the right middle lung field. Bronchoscopic biopsy was
performed, and the pathological examination revealed
adenocarcinoma, which was considered to be colorectal in
origin, as proved by a positive immunostaining reaction
for cytokeratin 20 (Figure 1A) and caudal-related homeo-
domain transcription factor 2 (Figure 1B) as well as
immunostaining reaction for cytokeratin 7 (Figure 1C)
and thyroid transcription factor-1 (Figure 1D). The patient
was then referred to the outpatient Department of Colo-
rectal Surgery. After admission, a series of analyses were
performed. The general examination was unremarkable,
with no lymphadenopathy, and laboratory studies revealed
a hemoglobin concentration of 11.9 g/dL, a white blood
cell count of 5,800 cells/μL, and a platelet count of
154,000 cells/μL. Renal and liver function tests were nor-
mal, and hepatitis markers were negative. Serum carci-
noembryonic antigen and carbohydrate antigen 19-9 levels
were 214 ng/mL and 1.21 U/mL, respectively. A complete
colonoscopy revealed an annular ulcerative lesion in the
sigmoid colon (25 cm above the anal verge). Biopsy
of the tumor was performed, which revealed a moderately. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Histological appearance of the lung biopsy specimen. Malignant tumor cells were arranged in clusters and an acinar pattern,
suggestive of adenocarcinoma. (A) Positive immunohistochemical staining for cytokeratin 20. (B) Positive immunohistochemical staining
for caudal-related homeodomain transcription factor 2. (C) Negative immunohistochemical staining for cytokeratin 7. (D) Negative immunohistochemical
staining for thyroid transcription factor-1.
Lin et al. World Journal of Surgical Oncology 2014, 12:147 Page 2 of 5
http://www.wjso.com/content/12/1/147differentiated colon adenocarcinoma. Computed tomog-
raphy of the abdomen and pelvis revealed mesenteric
lymphadenopathies associated with a mass in the sigmoid
colon (Figure 2A, arrow). There was no liver metastasis.
Computed tomography of the thorax revealed a 3.2-cm
nodule in the right middle lung field that was consist-
ent with lung metastasis (Figure 2B, arrow). The patient
underwent anterior resection associated with regionalFigure 2 Computed tomography (CT) of the abdomen and chest. (A)
compatible with colon cancer (arrow). (B) Chest CT revealed a 3.2-cm nodulymphadenectomy, with the pathological assessment of
the resected specimen revealing a collision tumor consist-
ing of a moderately differentiated adenocarcinoma extend-
ing through the muscularis propria and low-grade B-cell
lymphoma. Extramural vascular invasion of the adenocar-
cinoma cells was present. Interestingly, there were several
granulomatous lesions on the resected sigmoid colon.
Acid-fast staining and polymerase chain reaction analysisAbdominal CT revealed wall thickening of the sigmoid colon, which is
le in the right middle lung field (arrow).
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scopic evaluation of the 19 regional lymph nodes in the
mesentery of the resected colon showed diffuse infiltration
of low-grade B-cell lymphoma in the lymph node architec-
ture. In one lymph node, metastasis of adenocarcinoma
was also present. According to immunohistochemistry,
the cells were positive for cluster of differentiation (CD)
20, B-cell lymphoma (Bcl)-2, and CD10 (weak), and nega-
tive for CD3, CD5, CD23, Bcl-6, terminal deoxynucleoti-
dyl transferase, and cyclin D1. The proliferation fraction
(MIB-1 immunostaining) was approximately 15%. The
morphological and immunohistochemical findings were
used to confirm the diagnosis of synchronous presentation
of low-grade B-cell lymphoma and colon adenocarcinoma
within the sigmoid colon tumor and mesenteric lymph
nodes. Furthermore, microscopic examination of the spleen
revealed infiltration of the specimen by low-grade B-cell
lymphoma with proliferation of small to medium-sized cells
(Figure 3). K-RAS and B-RAF genetic mutations were evalu-
ated in the primary tumor DNA after microdissection,
and both genes were determined to be the wild type.
Three weeks after surgery, the patient was scheduled to
undergo a bone marrow biopsy for lymphoma staging, but
he declined because of his advanced age and general poor
condition.
After discussion of this case in a multidisciplinary team
treatment conference for colorectal cancer, the patient
underwent palliative chemotherapy with modified fluoro-
uracil, leucovorin, and oxaliplatin (mFOLFOX6) for six
cycles. However, he presented with grade III periph-
eral neuropathy in both hands and feet. On the basis
of the late stage of the bowel malignancy, advanced age,
and complexity of comorbidities of the patient, we pro-
posed a palliative treatment with capecitabine, which is
ongoing. He also received tuberculosis (TB) treatment,Figure 3 The spleen was infiltrated by low-grade B-cell
lymphoma with the proliferation of small-to-medium-sized
cells. Hematoxylin and eosin, original magnification, ×100.which included ethambutol, rifampicin, isoniazid, and pyr-
azinamide for the first 2 months, and then ethambutol,
rifampicin, and isoniazid for the next 6 months, after extra-
pulmonary TB was detected. He was regularly followed-up
as an outpatient. The patient has remained in a stable con-
dition for 24 months after surgical resection of the colon.
Discussion
To our knowledge, this report is the first case of a collision
tumor of low-grade B-cell lymphoma and adenocarcinoma
in the same colonic segment, and retrieved lymph nodes
coexisting with a TB infection.
The coexistence of TB and carcinoma is well docu-
mented in the lungs, skin, and larynx. However, the sim-
ultaneous occurrence of these two diseases is rarely
observed in the colon. Chronic diseases, such as ulcera-
tive colitis and Crohn’s disease, are known to increase the
risk of malignancy, but the causal relationship between
carcinoma and TB in the colon is still unclear [11]. The
etiological relationship between the two diseases is a mat-
ter of debate. The coexistence of TB and adenocarcinoma
in the colon may be coincidental, or one disease process
might have initiated the other [12-14]. Falagas et al. [15]
reported that clinicians need to be aware of the protean
manifestations of TB and cancer, and they should main-
tain a high index of suspicion for simultaneous and/or
misleading presentations. TB and various types of malig-
nancies can mimic each other and have atypical clinical
and radiological expressions. Further research is required
to determine whether TB infection, being similar to other
chronic infections and inflammatory conditions, may fa-
cilitate carcinogenesis.
Molecular genetic analysis is of special importance for
the diagnosis of collision tumors consisting of poorly dif-
ferentiated neoplasms, such as peripheral T-cell lymph-
oma and anaplastic carcinoma, particularly when the
results of immunohistochemistry are inconclusive. We be-
lieve that collision tumors consisting of large cell NHL
and carcinoma would be detected more often if molecular
genetic analysis were used more extensively [4]. Although
we were unable to identify any common etiologic factor of
the two malignancies in our patient, we believe that their
synchronous presentation is purely coincidental. Never-
theless, in addition to its uniqueness, the situation of this
patient offers several therapeutic challenges for clinicians.
The advanced age of the patient, metastatic colorectal
cancer, the influence of one malignancy on the natural his-
tory of another, and extra-pulmonary TB increased the
complexity of treatment.
There are some hypotheses suggesting the etiology of
collision tumors. One hypothesis is that the two primary
tumors arise in continuity through a chance accidental
‘meeting’. On the contrary, to date, there are no known
common etiologic factors for the occurrence of both
Table 1 Cases of collision tumors of primary malignant lymphoma and adenocarcinoma in the colon reported
Source Year Age (years)/
Sex
Tumor location Tumor type Pathological
stage
Treatment Prognosis
Cornes et al. [1] 1960 63/M Rectum Lymphocytic lymphosarcoma pT3N0M0 NA NA
Aitani et al. [2] 1987 59/M Transverse colon Diffuse large B-cell lymphoma NA NA Alive
Chazouillères et al. [3] 1990 56/F Rectum Lymphoma NA NA NA
Mannweiler et al. [4] 2003 73/M Rectum T-cell lymphoma pT2N0M0 NA NA
Minato et al. [5] 2004 80/M Ascending colon Diffuse large B-cell lymphoma NA NA 5 months, died
of pneumonia
Sasaki et al. [6] 2010 62/M Cecum Follicular lymphoma pT3N0M0 CHOP + Rituximab Alive
Takashi et al. [7] 2011 76/F Ileocecal Diffuse large B-cell lymphoma pT3N1M0 NA 5 months, died
of lymphoma
Chang et al. [8] 2011 NA Ileocecal Diffuse large B-cell lymphoma NA NA NA
Our case 2014 81/M Sigmoid colon Low-grade B-cell lymphoma pT3N1aM1 mFOLFOX6 Alive
NA, Not available; CHOP, Cyclophosphamide, doxorubicin, vincristine, and prednisone; mFOLFOX, Modified fluorouracil, leucovorin, and oxaliplatin.
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Another hypothesis is that the presence of the first
tumor alters the microenvironment, precipitating the de-
velopment of the second adjacent tumor [7].
In our case, the pre-operative examinations were un-
able to reveal lymphoma adjacent to adenocarcinoma.
Further intensive investigations may help to detect the
existence of collision tumors. Herein, we reported a rare
case of collision tumors (adenocarcinoma and low-grade
B-cell lymphoma) in the colon. A therapeutic dilemma
exists in deciding the course of treatment in patients
with collision tumors. Collision tumors of two types,
similar to the current case, were previously observed in
8 patients, as listed in Table 1. The age of the patients
ranged from 59 to 81 years, with a mean age of 68.9 years.
The male to female ratio was 3:1. Adenocarcinomas and
lymphomas were located in the right colon, left colon, and
rectum in 5, 1, and 3 patients, respectively. Previous re-
ports have been limited because of the rarity of such colli-
sion tumors, and most reports did not describe the course
of the disease after diagnosis. Sasaki et al. [6] reported that
a patient received six courses of combined chemotherapy
(cyclophosphamide, doxorubicin, vincristine, and prednis-
one regimen with rituximab) against malignant lymph-
oma, which yielded a complete response. In our case,
the patient underwent six courses of chemotherapy with
mFOLFOX6 followed by capecitabine to treat sigmoid
colon adenocarcinoma with lung metastasis. Takashi et al.
[7] reported a patient who died because of the peritoneal
recurrence of malignant lymphoma.
Conclusions
This clinical course clearly suggested the difficulty of
selecting the optimal therapy for collision tumors of differ-
ent malignant entities, and the importance of close follow-
up for both lesions. More cases should be reported in the
literature to define the principle management in suchchallenging scenarios. Moreover, pathologists should be
aware of the existence of collision tumors in the small and
large intestines. The appropriate selection of immunohis-
tochemical tests may help to establish the diagnosis. Im-
munohistochemical results can be resolved by molecular
analysis, particularly when lymphomas are components of
collision tumors of the colon.
Consent
Written informed consent was obtained from the patient
for publication of this case report and the accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
Abbreviations
Bcl: B-cell lymphoma; CD: Cluster of differentiation; mFOLFOX: Modified
fluorouracil, leucovorin, and oxaliplatin; NHL: Non-Hodgkin’s lymphoma;
TB: Tuberculosis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors participated in the conception and design of the study. HL
performed the clinical analysis and drafted the manuscript. JL performed
surgery and supervised the study. HL, JJ, and JL were involved in the final
editing. All authors read and approved the final manuscript.
Received: 8 March 2014 Accepted: 29 April 2014
Published: 11 May 2014
References
1. Cornes JS: Multiple primary cancers: primary malignant lymphomas and
carcinomas of the intestinal tract in the same patient. J Clin Pathol 1960,
13:483–489.
2. Aitani MK, Watanabe M, Yamamoto T, Kimura Y, Saeki K: A case of
synchronous double primary malignant lymphoma and adenocarcinoma
(collision tumor) of transverse colon. Osaka Keisatsubyou ishi 1987,
11:97–103.
3. Chazouilleres O, Andreani T, Boucher JP, Calmus Y, de Sigalony H,
Nordlinger R, Poupon R: Rectal adenocarcinoma in association with
lymphoma ("collision tumor"). Gastroenterol Clin Biol 1990, 14:185–186.
4. Mannweiler S, Dinges HP, Beham-Schmid C, Hauser H, Starlinger M,
Regauer S: Colliding/concomitant tumors of the intestine: report of 3 cases.
Pathol Oncol Res 2003, 9:188–192.
Lin et al. World Journal of Surgical Oncology 2014, 12:147 Page 5 of 5
http://www.wjso.com/content/12/1/1475. Minato EF, Sugihara N, Matsumoto K, Shima K: A case of collision tumor of
primary malignant lymphoma and poorly-differentiated adenocarcinoma
in the ascending colon. Nippon Shokakigeka Gakkaizasshi (Jpn J
Gastroenterol Surg) 2004, 37:213–216.
6. Sasaki S, Hatanaka K, Sahara N, Uekusa T, Hirayama K, Shirahata A, Ishimaru M:
Collision tumor of primary malignant lymphoma and adenocarcinoma in
the colon: report of a case. Surg Today 2010, 40:975–981.
7. Shigeno T, Fujimori K, Tsuruta F, Nozawa Y, Nagaya T, Maejima T: Ileocecal
collision tumor composed of adenocarcinoma and primary malignant
lymphoma. Clin J Gastroenterol 2011, 4:79–84.
8. Chang H, Chuang WY, Shih LY, Tang TC: Collision in the colon: concurrent
adenocarcinoma and diffuse large B-cell lymphoma in the same tumour.
Acta Clin Belg 2011, 66:302–304.
9. Wong MT, Eu KW: Primary colorectal lymphomas. Colorectal Dis 2006,
8:586–591.
10. Ioannidis O, Cheva A, Kakoutis E, Athina K, Nikolaos P, Stergios R,
Makrantonakis N: Acute adult intussusception caused by primary cecal
non Hodgkin lymphoma. Acta Gastroenterol Belg 2011, 74:451–453.
11. Gopal SV, Panda S, Kadambari D, Srinivasan K: Carcinoma colon associated
with tuberculosis: an unusual presentation. Int J Colorectal Dis 2007,
22:843–844.
12. Maruta K, Tanaka S, Nakamura T, Hagio S, Sato E, Nishi M: Carcinoma of the
colon coexisting with tuberculosis–report of 2 cases. Gan No Rinsho 1983,
29:448–453.
13. Jain BK, Chandra SS, Narasimhan R, Ananthakrishnan N, Mehta RB:
Coexisting tuberculosis and carcinoma of the colon. Aust N Z J Surg 1991,
61:828–831.
14. Kaushik R, Sharma R, Attri AK: Coexisting tuberculosis and carcinoma of
the colon: a report of two cases and a review of the literature.
Trop Gastroenterol 2003, 24:137–139.
15. Falagas ME, Kouranos VD, Athanassa Z, Kopterides P: Tuberculosis and
malignancy. QJM 2010, 103:461–487.
doi:10.1186/1477-7819-12-147
Cite this article as: Lin et al.: Collision tumor of low-grade B-cell
lymphoma and adenocarcinoma with tuberculosis in the colon: a case
report and literature review. World Journal of Surgical Oncology
2014 12:147.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
